Dr. Catherine Bonuccelli joined Zeneca Pharmaceuticals from academics in 1994, and has
supported a variety of drug development projects across all phases of the product life cycle,
including the development-for-launch and post-launch phases. In addition, she has held many
different organizational roles outside of drug projects, including leading the creation and
implementation of organizational strategies to sustain long-term success in the area of drug
development, providing functional leadership for US Regulatory and Medical Affairs, and
providing senior medical representation for the US Business with key external scientific and
healthcare customers. Currently, she is Global Product Vice President for Symbicort,
AstraZeneca’s largest respiratory brand, with responsibility for global product strategy and
execution worldwide. Dr. Bonuccelli received her B.S. in Chemistry from Georgetown University
in 1979 and her M.D. from the Johns Hopkins University School of Medicine in 1983. She
completed her residency training in pediatrics and fellowship training in pediatric pulmonary at
Johns Hopkins Hospital, and is board certified in both pediatrics and pediatric pulmonary
medicine. Dr. Bonuccelli holds board positions for AI Dupont Children’s Hospital, the Delaware
Biotechnology Park, and the American College of Physicians Foundation.